(Q46161319)

20 December 2017

title

NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? (English)

1 reference

20 December 2017

0 references

5

Carlo Caltagirone

1 reference

20 December 2017

3

Maria Teresa Ciotti

1 reference

20 December 2017

author name string

Nicoletta Croce

1

1 reference

20 December 2017

Francesca Gelfo

2

1 reference

20 December 2017

Giorgio Federici

4

1 reference

20 December 2017

Sergio Bernardini

6

1 reference

20 December 2017

Francesco Angelucci

7

1 reference

20 December 2017

publication date

29 January 2013

1 reference

20 December 2017

Molecular and Cellular Biochemistry

published in

1 reference

20 December 2017

volume

376

1 reference

20 December 2017

issue

1-2

1 reference

20 December 2017

page(s)

189-195

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11010-013-1567-0

exact match

0 references

cites work

Aging, metabolism, and Alzheimer disease: review and hypotheses

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

New insights into brain BDNF function in normal aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Neuropeptide Y protects rat cortical neurons against β-amyloid toxicity and re-establishes synthesis and release of nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

MicroRNA function and neurotrophin BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment and translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

The toxicity in vitro of beta-amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Neuropeptide Y functions as a neuroproliferative factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

A brain-specific microRNA regulates dendritic spine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Requirement for BDNF in activity-dependent survival of cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Differentiation/maturation of neuropeptide Y neurons in the corpus callosum is promoted by brain-derived neurotrophic factor in mouse brain slice cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1567-0

Nerve growth factor regulates galanin and neuropeptide Y expression in primary cultured superior cervical ganglion neurons

21 January 2018

1 reference

12 December 2020

Neuropeptide Y: Neurotransmitter or Trophic Factor in the Heart?

1 reference

12 December 2020

Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity

1 reference

12 December 2020

Comprehensive algorithm for quantitative real-time polymerase chain reaction

1 reference

12 December 2020

Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells

1 reference

12 December 2020

10.1007/S11010-013-1567-0

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017